Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
KALA BIO
Acquired Company
Nationwide telehealth platform
WashingtonWashingtonBiotechnologyHealth CareHealth CareDescription
KALA BIO, Inc. has signed a non-binding letter of intent to acquire a telehealth platform in a deal valued at USD 15 million. The acquisition aims to enhance KALA BIO's capabilities beyond its current focus on ophthalmology programs. The target telehealth platform has generated USD 12.7 million in trailing revenue through August 2026. This acquisition proposal is still pending completion.
Fundz sees it the moment KALA BIO makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Nationwide telehealth platform?
Nationwide telehealth platform was acquired by KALA BIO, based in Washington. The deal was reported on October 16, 2026. KALA BIO, Inc. is a biotechnology company focused on developing innovative therapies. The company is working on Researgency.ai, an enterprise agentic platform for biopharmaceutical research. KALA BIO is privately held and operates in Biotechnology.
When did KALA BIO acquire Nationwide telehealth platform?
KALA BIO's acquisition of Nationwide telehealth platform was reported on October 16, 2026. KALA BIO, Inc. has signed a non-binding letter of intent to acquire a telehealth platform in a deal valued at USD 15 million. The acquisition aims to enhance KALA BIO's capabilities beyond its current focus on ophthalmology programs. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nationwide telehealth platform do?
The telehealth platform provides services to over 90,000 clients since its founding in 2023. It generated USD 12.7 million in trailing revenue through August 2026. The platform focuses on delivering remote healthcare services and solutions. It is privately held, operating in Health Care, and is based in Washington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.